Key Insights:
- Since 2022, the field of gastroenterology and hepatology has witnessed significant advancements in artificial intelligence (AI), expected to revolutionize patient care. However, global discussions have raised concerns regarding the adoption of AI, including issues with accuracy, reliability, and privacy.
- Dr. Thomas R. McCarty and Dr. Nabil M. Mansour highlight the profound impact of AI, particularly in gastrointestinal endoscopy. The technology has been used in various applications, ranging from lesion detection during colonoscopy to innovations in small bowel, esophageal, and hepatobiliary conditions.
- Despite promising data from randomized controlled trials (RCTs) showing that AI can improve adenoma detection rates (ADR), recent real-world studies report no improvement, questioning the efficacy of AI under routine clinical conditions. This discrepancy raises significant questions about the potential biases in prospective trials and the actual benefits of AI in practice.
The integration of AI into gastroenterology and hepatology offers exciting possibilities for enhancing diagnostic and therapeutic processes. However, the transition from controlled trials to everyday clinical use poses challenges that require careful consideration of both the technology’s limitations and its interaction with human operators to ensure it truly enhances patient care.